Gilead Sciences (GILD) Revenue — Quarter Ended Jun 30, 2024
Revenue increased in the latest quarter, reflecting positive momentum. The performance showed improvement compared to both the prior quarter and the same period last year.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue increased in the latest quarter, reflecting positive momentum. The performance showed improvement compared to both the prior quarter and the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7B
Revenue reported for this quarter.
Quarter-over-quarter
+4.0%
Change from the immediately preceding quarter.
Year-over-year
+5.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$27.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $7.1B | +0.1% |
| Dec 31, 2023 | $7.1B | -3.7% |
| Mar 31, 2024 | $6.7B | +5.3% |
| Jun 30, 2024 | $7B | +5.4% |
Revenue performance
The company delivered higher revenue for the quarter, continuing an upward trend from the preceding period.
Quarterly comparison
Compared to the immediate prior quarter, revenue grew, and it also rose relative to the same quarter one year earlier.
What to watch
The sustainability of revenue growth remains a key point to monitor.